{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:38:11Z","timestamp":1782603491183,"version":"3.54.5"},"reference-count":64,"publisher":"Scientific Scholar","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/0971-4065.202824","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T08:32:51Z","timestamp":1490257971000},"page":"249","source":"Crossref","is-referenced-by-count":11,"title":["Proton pump inhibitors: More indigestion than relief?"],"prefix":"10.25259","volume":"27","author":[{"given":"P","family":"Malavade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Hiremath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.202824-1","unstructured":"Church NC, Palmer KR. Acute non-variceal upper gastrointestinal haemorrhage treatment. In: McDonald J, Burroughs A, Feagan B, editors. Evidence Based Gastrology and Hepatology. London: BMJ Books; 1999. p. 118-38."},{"key":"key-10.4103\/0971-4065.202824-2","unstructured":"Ostrow B. Peptic Ulcer Disease \u2013 The Impact of Helicobacter pylori on Management in the Developing World. SIA; April, 2007."},{"key":"key-10.4103\/0971-4065.202824-3","first-page":"405","volume-title":"Systematic review: Hypomagnesaemia induced by proton pump inhibition","author":"Hess","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/0971-4065.202824-4","unstructured":"Wickersham RM, Novak KK. Drug Facts and Comparisons. St. Louis, MO: Wolters Kluwer Health, Inc.; 2005."},{"key":"key-10.4103\/0971-4065.202824-5","first-page":"S295","volume-title":"Gastroesophageal reflux and hyperacidity in chronic renal failure","author":"Fallone","year":"2001","journal-title":"Perit Dial Int"},{"key":"key-10.4103\/0971-4065.202824-6","first-page":"1455","volume-title":"Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients","author":"Wasse","year":"2003","journal-title":"Kidney Int"},{"key":"key-10.4103\/0971-4065.202824-7","first-page":"1352","volume-title":"Gastroesophageal reflux disease in chronic renal failure patients with upper GI symptoms: Multivariate analysis of pathogenetic factors","author":"Cekin","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/0971-4065.202824-8","first-page":"S11","volume-title":"Gastrointestinal disease and the kidney","author":"de","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key-10.4103\/0971-4065.202824-9","unstructured":"IMS Institute for Healthcare Informatics. Medicine Use and Shifting Costs of Healthcare: A Review of the Use of Medicines in the United States in 2013; April 2014. Available from: http:\/\/www.imshealth.com\/cds\/imshealth\/Global\/Content\/Corporate\/IMS%20Health%20Institute\/Reports\/Secure\/IIHI_USUse_of_Meds_for_2013.pdf. [Last accessed on 2015 Jun 19]."},{"key":"key-10.4103\/0971-4065.202824-10","first-page":"570","volume-title":"Overuse of acid suppressant drugs in patients with chronic renal failure","author":"Strid","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.202824-11","first-page":"180","volume-title":"Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: The Dialysis Outcomes and Practice Patterns Study (DOPPS)","author":"Bailie","year":"2006","journal-title":"Hemodial Int"},{"key":"key-10.4103\/0971-4065.202824-12","first-page":"209","volume-title":"Hypergastrinaemia in chronic renal failure","author":"Korman","year":"1972","journal-title":"Br Med J"},{"key":"key-10.4103\/0971-4065.202824-13","first-page":"500","volume-title":"Pantoprazole, Prout and the proton pump","author":"Playford","year":"1999","journal-title":"Hosp Med"},{"key":"key-10.4103\/0971-4065.202824-14","first-page":"52","volume-title":"Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases","author":"Welage","year":"2000","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"key-10.4103\/0971-4065.202824-15","first-page":"3","volume-title":"Review article: The pharmacology of rabeprazole","author":"Williams","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/0971-4065.202824-16","first-page":"261","volume-title":"Rabeprazole","author":"Prakash","year":"1998","journal-title":"Drugs"},{"key":"key-10.4103\/0971-4065.202824-17","first-page":"S11","volume-title":"Safety profile of the proton-pump inhibitors","author":"Reilly","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"key-10.4103\/0971-4065.202824-18","first-page":"27","volume-title":"Proton-pump inhibitors for gastric acid-related disease","author":"Franko","year":"1998","journal-title":"Cleve Clin J Med"},{"key":"key-10.4103\/0971-4065.202824-19","first-page":"473","volume-title":"Lansoprazole.An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders","author":"Langtry","year":"1997","journal-title":"Drugs"},{"key":"key-10.4103\/0971-4065.202824-20","unstructured":"Omeprazole (Prilosec). Package Insert. Wayne, PA: Astra Pharmaceuticals; 1998. Available from:http:\/\/www.azpicentral.com\/prilosec\/prilosec.pdf#page=1. [Last retrieved on 2016 Aug 29]."},{"key":"key-10.4103\/0971-4065.202824-21","unstructured":"Lansoprazole (Prevacid). Package Insert. Deerfield, Ill.: TAP Pharmaceuticals; 1999. Available from: http:\/\/www.abbott.ca\/docs\/PREVACID-PM-E.pdf. [Last retrieved on 2016 Aug 29]."},{"key":"key-10.4103\/0971-4065.202824-22","unstructured":"Rabeprazole (Aciphex). Package Insert. Titusville, NJ: Janssen Pharmaceuticals; 1999. Available from:http:\/\/www.aciphex.com\/pdf\/aciphexpi.pdf. [Last retrieved on 2016 Aug 29]."},{"key":"key-10.4103\/0971-4065.202824-23","unstructured":"Pantoprazole (Protonix). Package Insert. Philadelphia, PA: Wyeth-Ayerst; 2000. Available from: http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=135. [Last retrieved on 2016 Aug 29]."},{"key":"key-10.4103\/0971-4065.202824-24","unstructured":"Esomeprazole (Nexium). Package Insert. Wilmington, Del.: Astra Pharmaceuticals; 2001. http:\/\/www.azpicentral.com\/nexium-i-v\/nexium_iv.pdf#page=1. [Last retrieved on 2016 Aug 29]."},{"key":"key-10.4103\/0971-4065.202824-25","first-page":"2947","volume-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"key-10.4103\/0971-4065.202824-26","first-page":"e0128004","volume-title":"Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: A systematic review and meta-analysis","author":"Lambert","year":"2015","journal-title":"PLoS One"},{"key":"key-10.4103\/0971-4065.202824-27","first-page":"33","volume-title":"Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: Cohort and case-control studies","author":"Dial","year":"2004","journal-title":"CMAJ"},{"key":"key-10.4103\/0971-4065.202824-28","first-page":"410","volume-title":"Association of Proton pump inhibitors with risk of dementia: A pharmaco epidemiological claims data analysis","author":"Gomm","year":"2016","journal-title":"JAMA Neurol"},{"key":"key-10.4103\/0971-4065.202824-29","first-page":"472","volume-title":"Acute interstitial nephritis due to omeprazole","author":"Ruffenach","year":"1992","journal-title":"Am J Med"},{"key":"key-10.4103\/0971-4065.202824-30","first-page":"1441","volume-title":"Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: Experience from a single UK renal unit","author":"Torpey","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.202824-31","first-page":"12","volume-title":"Acute interstitial nephritis in the elderly: A report from the UK MRC glomerulonephritis register and a review of the literature","author":"Davison","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.202824-32","first-page":"221","volume-title":"Renal biopsy in patients with unexplained renal impairment and normal kidney size","author":"Farrington","year":"1989","journal-title":"Q J Med"},{"key":"key-10.4103\/0971-4065.202824-33","first-page":"2527","volume-title":"Diagnosis and management of acute interstitial nephritis","author":"Kodner","year":"2003","journal-title":"Am Fam Physician"},{"key":"key-10.4103\/0971-4065.202824-34","first-page":"506","volume-title":"Acute interstitial nephritis","author":"Michel","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/0971-4065.202824-35","first-page":"8","volume-title":"The changing profile of acute tubulointerstitial nephritis","author":"Baker","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.202824-36","first-page":"545","volume-title":"Systematic review: Proton pump inhibitor-associated acute interstitial nephritis","author":"Sierra","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/0971-4065.202824-37","first-page":"150","volume-title":"Proton pump inhibitors and acute kidney injury: A nested case-control study","author":"Klepser","year":"2013","journal-title":"BMC Nephrol"},{"key":"key-10.4103\/0971-4065.202824-38","first-page":"E166","volume-title":"Proton pump inhibitors and the risk of acute kidney injury in older patients: A population-based cohort study","author":"Antoniou","year":"2015","journal-title":"CMAJ Open"},{"key":"key-10.4103\/0971-4065.202824-39","first-page":"238","volume-title":"Proton pump inhibitor use and the risk of chronic kidney disease","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"key":"key-10.4103\/0971-4065.202824-40","doi-asserted-by":"crossref","unstructured":"Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, Al-Aly Z. Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol 2016. pii: ASN.2015121377.","DOI":"10.1681\/ASN.2015121377"},{"key":"key-10.4103\/0971-4065.202824-41","first-page":"694","volume-title":"Routine prophylaxis with proton pump inhibitors and post-transplant complications in kidney transplant recipients undergoing early corticosteroid withdrawal","author":"Courson","year":"2016","journal-title":"Clin Transplant"},{"key":"key-10.4103\/0971-4065.202824-42","first-page":"775","volume-title":"Proton pump inhibitors and hypomagnesemia in the general population: A population-based cohort study","author":"Kieboom","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.202824-43","first-page":"166","volume-title":"Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family","author":"Schlingmann","year":"2002","journal-title":"Nat Genet"},{"key":"key-10.4103\/0971-4065.202824-44","first-page":"3495","volume-title":"Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis 1.Oral absorption of magnesium","author":"Bai","year":"2012","journal-title":"Mol Pharm"},{"key":"key-10.4103\/0971-4065.202824-45","first-page":"684","volume-title":"Apical acidity decreases inhibitory effect of omeprazole on Mg(2+) absorption and claudin-7 and-12 expression in caco-2 monolayers","author":"Thongon","year":"2012","journal-title":"Exp Mol Med"},{"key":"key-10.4103\/0971-4065.202824-46","first-page":"e0143656","volume-title":"Proton pump inhibitor use and magnesium concentrations in hemodialysis patients: A cross-sectional study","author":"Nakashima","year":"2015","journal-title":"PLoS One"},{"key":"key-10.4103\/0971-4065.202824-47","first-page":"112","volume-title":"A case series of proton pump inhibitor-induced hypomagnesemia","author":"Hoorn","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.202824-48","first-page":"2151","volume-title":"Serum and dietary magnesium and the risk for type 2 diabetes mellitus: The Atherosclerosis Risk in Communities Study","author":"Kao","year":"1999","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/0971-4065.202824-49","first-page":"926","volume-title":"Magnesium intake, bone mineral density, and fractures: Results from the Women's Health Initiative Observational Study","author":"Orchard","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"key-10.4103\/0971-4065.202824-50","first-page":"33","volume-title":"Low serum magnesium and the development of atrial fibrillation in the community: The Framingham Heart Study","author":"Khan","year":"2013","journal-title":"Circulation"},{"key":"key-10.4103\/0971-4065.202824-51","first-page":"160","volume-title":"Circulating and dietary magnesium and risk of cardiovascular disease: A systematic review and meta-analysis of prospective studies","author":"Del","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"key-10.4103\/0971-4065.202824-52","first-page":"256","volume-title":"Electrolyte disorders in community subjects: Prevalence and risk factors","author":"Liamis","year":"2013","journal-title":"Am J Med"},{"key":"key-10.4103\/0971-4065.202824-53","first-page":"820","volume-title":"Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease","author":"Tin","year":"2015","journal-title":"Kidney Int"},{"key":"key-10.4103\/0971-4065.202824-54","first-page":"4003","volume-title":"Hypomagnesaemia, the kidney and the vessels","author":"Van","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.202824-55","first-page":"203","volume-title":"Magnesium chemistry and biochemistry","author":"Maguire","year":"2002","journal-title":"Biometals"},{"key":"key-10.4103\/0971-4065.202824-56","first-page":"e59891","volume-title":"Regulation and function of TRPM7 in human endothelial cells: TRPM7 as a potential novel regulator of endothelial function","author":"Baldoli","year":"2013","journal-title":"PLoS One"},{"key":"key-10.4103\/0971-4065.202824-57","first-page":"645","volume-title":"Influence of extracellular magnesium on capillary endothelial cell proliferation and migration","author":"Banai","year":"1990","journal-title":"Circ Res"},{"key":"key-10.4103\/0971-4065.202824-58","first-page":"31","volume-title":"Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification","author":"Salem","year":"2012","journal-title":"Am J Nephrol"},{"key":"key-10.4103\/0971-4065.202824-59","first-page":"586","volume-title":"Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions","author":"Dong","year":"2008","journal-title":"Thromb Haemost"},{"key":"key-10.4103\/0971-4065.202824-60","first-page":"3620","volume-title":"Early administration of intravenous magnesium inhibits arterial thrombus formation","author":"Ravn","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key-10.4103\/0971-4065.202824-61","first-page":"920","volume-title":"Inflammation, kidney function and albuminuria in the Framingham Offspring cohort","author":"Upadhyay","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.202824-62","first-page":"174","volume-title":"Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis","author":"Sakaguchi","year":"2014","journal-title":"Kidney Int"},{"key":"key-10.4103\/0971-4065.202824-63","first-page":"237","volume-title":"Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients","author":"Ishimura","year":"2007","journal-title":"Magnes Res"},{"key":"key-10.4103\/0971-4065.202824-64","first-page":"1047","volume-title":"Hypomagnesemia and mortality in incident hemodialysis patients","author":"Li","year":"2015","journal-title":"Am J Kidney Dis"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:40:47Z","timestamp":1712173247000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/proton-pump-inhibitors-more-indigestion-than-relief\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"alternative-id":["202824"],"URL":"https:\/\/doi.org\/10.4103\/0971-4065.202824","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}